O. Georgiev

发表

Expression Levels of p53 Messenger RNA Detected by Real Time PCR in Tumor Tissue, Lymph Nodes and Peripheral Blood of Patients with Non-Small Cell Lung Cancer—New Perspectives for Clinicopathological Application

D. Toncheva, R. Cherneva, O. Georgiev, 2009 .

Gemifloxacin once daily for 5 days versus 7 days for the treatment of community-acquired pneumonia: a randomized, multicentre, double-blind study.

L. Mandell, T. File, O. Georgiev, 2007, The Journal of antimicrobial chemotherapy.

Pericardial Effusion in Obstructive Sleep Apnea without Pulmonary Arterial Hypertension and Daily Hypoxemia - is it Unusual?

O. Georgiev, E. Manov, V. Pencheva, 2018, Balkan medical journal.

Sleep and Chronic Obstructive Pulmonary Disease – the Role of Oxidative Stress in Overlap Syndrome

R. Cherneva, O. Georgiev, E. Manov, 2014 .

Chronic Obstructive Pulmonary Disease – Chaperonopathology

R. Cherneva, O. Georgiev, D. Petrova, 2012 .

The role of small heat-shock protein αB-crystalline (HspB5) in COPD pathogenesis

R. Cherneva, O. Georgiev, D. Petrova, 2012, International journal of chronic obstructive pulmonary disease.

Resistin - the link between adipose tissue dysfunction and insulin resistance in patients with obstructive sleep apnea

R. Cherneva, O. Georgiev, V. Mitev, 2013, Journal of Diabetes & Metabolic Disorders.

Pneumonia and in-hospital mortality after renal transplantation

O. Georgiev, V. Pencheva, D. Petrova, 2017 .

Acute Respiratory Distress Syndrome in Renal Transplant Patients with Pneumonia

O. Georgiev, V. Pencheva, D. Petrova, 2014 .

Resistin and Cardiac Remodeling in Patients with Obstructive Sleep Apnea

R. Cherneva, O. Georgiev, E. Manov, 2014 .

Gemiﬂoxacin once daily for 5 days versus 7 days for the treatment of community-acquired pneumonia: a randomized, multicentre, double-blind study

L. Mandell, O. Georgiev, K. Kostov, 2007 .

Assessment of the expectancy, seriousness and severity of adverse drug reactions reported for chronic obstructive pulmonary disease therapy

O. Georgiev, A. Stoimenova, M. Kamusheva, 2017, SAGE open medicine.

Nocturnal Hypertension, Nondipping Phenomenon and Target Organ Damage in Obstructive Sleep Apnea Patients - The Bad and the Worse

R. Cherneva, O. Georgiev, E. Manov, 2014 .

Pitolisant for Daytime Sleepiness in Patients with Obstructive Sleep Apnea Who Refuse Continuous Positive Airway Pressure Treatment. A Randomized Trial

J. Pépin, J. Schwartz, M. Partinen, 2020, American Journal of Respiratory and Critical Care Medicine.

Pitolisant for Residual Excessive Daytime Sleepiness in OSA Patients Adhering to CPAP

J. Pépin, J. Schwartz, M. Partinen, 2022, Chest.

Resistin and Oxidative Stress in Non-Diabetic Obstructive Sleep Apnea Patients with Nocturnal Hypertension

R. Cherneva, O. Georgiev, E. Manov, 2014 .

Clinical usefulness of alpha-crystallin antibodies in non-small cell lung cancer patients.

R. Cherneva, O. Georgiev, D. Petrov, 2010, Interactive cardiovascular and thoracic surgery.

Clinical Factors and Biomarkers Associated with the Non-Dipping Profilein Obstructive Sleep Apnea Patients with Metabolic Syndrome

R. Cherneva, O. Georgiev, D. Petrova, 2014 .

Risk factors for lung diseases after renal transplantation

O. Georgiev, V. Pencheva, D. Petrova, 2015, Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences.

EGFR and hTERT Expression as a Diagnostic Approach for Non-small Cell Lung Cancer in High Risk Groups

D. Toncheva, R. Cherneva, O. Georgiev, 2010, Biomarkers in cancer.

Connective tissue disease related interstitial lung diseases and idiopathic pulmonary fibrosis: provisional core sets of domains and instruments for use in clinical trials

Ami A. Shah, R. Hubbard, W. Dixon, 2013, Thorax.

Obstructive Sleep Apnea patients adhering to Continuous positive Airway Pressure: A randomized trial.

J. Pépin, J. Schwartz, M. Partinen, 2020, Chest.

Pitolisant for Daytime Sleepiness in Patients with Obstructive Sleep Apnea Who Refuse Continuous Positive Airway Pressure Treatment. A Randomized Trial

J. Pépin, J. Schwartz, M. Partinen, 2020, American journal of respiratory and critical care medicine.

8‐isoprostanes and resistin as markers of vascular damage in non‐hypersomnolent obstructive sleep apnoea patients

R. Cherneva, O. Georgiev, D. Petrova, 2016, Clinical physiology and functional imaging.

Early Detection of Lung Cancer: A Call for Novel Biomarkers-Review

R. Cherneva, O. Georgiev, D. Petrova, 2007 .

Cognitive Impairment and Affective Disorders in Patients With Obstructive Sleep Apnea Syndrome

V. Milanova, O. Georgiev, V. Pencheva, 2018, Front. Psychiatry.

8-isorpostanes – markers for oxidative stress in obstructive sleep apnea patients with systolic dysfunction

R. Cherneva, O. Georgiev, V. Mitev, 2013 .

Resistin as Marker of Metabolic and Cardiovascular Abnormalities in OSA Patients

R. Cherneva, O. Georgiev, E. Manov, 2014 .

Pulmonary Complications as a Cause of Death after Renal Transplantation

O. Georgiev, V. Pencheva, D. Petrova, 2014 .

Expression profile of the small heat-shock protein alpha-B-crystallin in operated-on non-small-cell lung cancer patients: clinical implication.

D. Toncheva, R. Cherneva, O. Georgiev, 2010, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

Obstructive sleep apnea syndrome and depressive symptoms.

V. Milanova, O. Georgiev, D. Petrova, 2009, Folia Medica.

Early Left Ventricular Function Abnormalities in Obstructive Sleep Apnea

R. Cherneva, O. Georgiev, E. Manov, 2014 .

FOCUS 2: a randomized, double-blinded, multicentre, Phase III trial of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in community-acquired pneumonia.

J. Milanowski, T. File, D. Górecka, 2011, The Journal of antimicrobial chemotherapy.

Connective tissue disease related interstitial lung diseases and idiopathic pulmonary fibrosis: provisional core sets of domains and instruments for use in clinical trials

Ami A. Shah, R. Hubbard, W. Dixon, 2013, Thorax.

8-isorpostanes – markers for oxidative stress in obstructive sleep apnea patients with systolic dysfunction

R. Cherneva, O. Georgiev, V. Mitev, 2013 .